NCT04175665View on ClinicalTrials.gov

Real-world Health Outcomes in Canadian Patients Using Semaglutide

CompletedOBSERVATIONAL
Enrollment

1,133

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

February 9, 2020

Study Completion Date

February 9, 2020

Conditions
Type 2 Diabetes
Interventions
DRUG

Semaglutide

Prescription for semaglutide as part of usual clinical practice

Trial Locations (1)

M4G 3E8

LMC Diabetes & Endocrinology, Toronto

All Listed Sponsors
lead

LMC Diabetes & Endocrinology Ltd.

OTHER

NCT04175665 - Real-world Health Outcomes in Canadian Patients Using Semaglutide | Biotech Hunter | Biotech Hunter